Nucleotides Cytidine and Uridine Associated with Vitamin B12 vs B-Complex Vitamins in the Treatment of Low Back Pain: The NUBES Study

We report the results of low back pain treatment using a combination of nucleotides, uridine (UTP), cytidine (CMP) and vitamin B , vs a combination of vitamins B , B , and B . Randomized, double-blind, controlled trial, of a 60-day oral treatment: Group A (n=317) receiving nucleotides+B and Group B...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of pain research 2020-01, Vol.13, p.2531-2541
Hauptverfasser: Mibielli, Marco Antonio Naslausky, Nunes, Carlos Pereira, Goldberg, Henrique, Buchman, Luiz, Oliveira, Lisa, Mezitis, Spyros G E, Wajnzstajn, Fernanda, Kaufman, Renato, Nigri, Rafael, Cytrynbaum, Natasha, Cunha, Karin Soares, Santos, Alessandra, Goldberg, Stephanie Wrobel, Platenik, Natália Carvalho, Rzetelna, Helio, Futuro, Daniel Bertoluci, Da Fonseca, Adenilson de Souza, Geller, Mauro
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:We report the results of low back pain treatment using a combination of nucleotides, uridine (UTP), cytidine (CMP) and vitamin B , vs a combination of vitamins B , B , and B . Randomized, double-blind, controlled trial, of a 60-day oral treatment: Group A (n=317) receiving nucleotides+B and Group B (n=317) receiving B vitamins. The primary endpoint was the percentage of subjects in each group presenting adverse events (AEs). Secondary endpoints were visual analog scale (VAS) pain scores at Visit 2 (day 30) and Visit 3 (day 60) in relation to pretreatment values, Roland-Morris Questionnaire (RMQ) scores and finger-to-floor distance (FFD) (percentage of subjects per group presenting improvement ≥5 points and ≥3cm, respectively). Seventy-five (24%) and 105 (33%) subjects ( =0.21) presented 133 and 241 AEs, with 3159% of subjects presenting ≥2 AEs ( =0.0019) in Group A and Group B, respectively. Twenty-four subjects in Group B were discontinued due to AEs, while no AE-related discontinuations occurred in Group A (
ISSN:1178-7090
1178-7090
DOI:10.2147/JPR.S277024